DOI:
10.1055/s-00000019
Fortschritte der Neurologie · Psychiatrie
LinksClose Window
References
Coghill D, Banaschewski T, Lecendreux M et al.
European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder.
Eur Neuropsychopharmacol 2013;
23: 1208-1218
We do not assume any responsibility for the contents of the web pages of other providers.